Today: 8 February 2026
Subscribe
Browse Category

NASDAQ:CRON News 12 December 2025

Cronos Group Inc (CRON) Stock Surges as US Marijuana Rescheduling Buzz Returns — Latest News, Forecasts, and Key Catalysts (Dec. 12, 2025)

Cronos Group Inc (CRON) Stock Surges as US Marijuana Rescheduling Buzz Returns — Latest News, Forecasts, and Key Catalysts (Dec. 12, 2025)

Cronos Group shares jumped as much as 19% in premarket trading Dec. 12 after reports that President Trump may seek to reclassify marijuana as a Schedule III drug. Reuters and other outlets cited broad gains across cannabis stocks on the news. Cronos recently announced a strategic acquisition in the Netherlands, aiming for top market share in Europe's largest adult-use market. No final decisions on U.S. policy have been confirmed.
12 December 2025
··
Cronos Group Inc (CRON) Stock Surges as US Marijuana Rescheduling Buzz Returns — Latest News, Forecasts, and Key Catalysts (Dec. 12, 2025)

Cronos Group Inc (CRON) Stock Surges as US Marijuana Rescheduling Buzz Returns — Latest News, Forecasts, and Key Catalysts (Dec. 12, 2025)

Cronos Group shares jumped as much as 19% in premarket trading December 12 after reports said the Trump administration may seek to reclassify marijuana as a Schedule III drug. The move follows Cronos’ recent acquisition in the Netherlands, aimed at securing top market share in Europe’s largest adult-use cannabis market. No final U.S. policy decisions have been made.
12 December 2025
·

Stock Market Today

Roche share price set for Monday test after MS drug fenebrutinib data lands

Roche share price set for Monday test after MS drug fenebrutinib data lands

8 February 2026
Roche said its experimental MS drug fenebrutinib met the main goal in a late-stage study for primary progressive multiple sclerosis, showing “non-inferiority” to Ocrevus but with more frequent, reversible liver enzyme elevations and a higher share of fatal cases. Roche shares last closed down 0.6% at 356.40 francs. Investors await Monday’s webcast for more data and filing plans.
Chevron stock price on watch: oil jitters, insider filing and a key dividend date ahead

Chevron stock price on watch: oil jitters, insider filing and a key dividend date ahead

8 February 2026
Chevron shares rose 0.9% to $180.86 Friday, trailing a 1.89% gain in the U.S. energy sector. Oil prices reversed losses as traders weighed U.S.-Iran talks and Middle East risks. Chevron’s CTO Thomas Ryder Booth exercised and sold 6,000 shares at a $178.43 average, according to a Feb. 5 SEC filing. The company’s next dividend record date is Feb. 17.
Mastercard stock price: MA ends Friday at $548.74 — exec pay filing and U.S. jobs data next

Mastercard stock price: MA ends Friday at $548.74 — exec pay filing and U.S. jobs data next

8 February 2026
Mastercard shares closed down 0.6% at $548.74 Friday, while Visa and American Express finished higher. The company raised executive pay for its CFO and Chief Services Officer, and set a quarterly dividend of 87 cents per share for Feb. 9. Investors await key U.S. jobs and inflation data next week, with payment stocks sensitive to bond yield moves. Director Rima Qureshi reported a transfer of 12,083 shares for personal financial management.
Go toTop